Prostatis Group’s Broadcom AVGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.61M Buy
4,251
+239
+6% +$95.8K 0.37% 55
2026
Q1
$1.24M Sell
4,012
-198
-5% -$65.2K 0.32% 70
2025
Q4
$1.46M Buy
4,210
+3,555
+543% +$1.27M 0.35% 61
2025
Q3
$216K Buy
+655
New +$201K 0.05% 160
2024
Q1
Sell
-2,130
Closed -$237K 137
2023
Q4
$237K Buy
+2,130
New +$202K 0.1% 116

Other funds holding AVGO

Prostatis Group's AVGO Position: Q2 2026 in Review

Prostatis Group increased its Broadcom (AVGO) stake by 6% in Q2 2026, buying an estimated $95.8K and bringing the position to 4,251 shares worth $1.61M. The position accounts for 0.37% of the portfolio, ranked #55.

Prostatis Group first reported a position in AVGO in Q4 2023 and has held it in 5 quarters since. 4,819 funds tracked by Wall St. Rank hold AVGO as of Q2 2026.

  • Prostatis Group held 4,251 shares of Broadcom worth $1.61M as of Q2 2026.
  • Prostatis Group bought 239 Broadcom shares in Q2 2026, an estimated $95.8K.
  • Broadcom made up 0.37% of Prostatis Group's portfolio in Q2 2026, its #55 holding.
  • Prostatis Group first reported a position in Broadcom in Q4 2023 and has held it in 5 quarters since.
  • 4,819 funds tracked by Wall St. Rank held Broadcom as of Q2 2026.

Based on Prostatis Group's 13F filing for Q2 2026, filed 14 Aug 2026.